Fabrinet Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Fabrinet on March 14, 2013, with the earliest event reported on the same date. The filing details the entry into a material definitive agreement regarding a secondary offering of shares by selling shareholders.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a share sale transaction.
- Shares Offered: 3,800,000 ordinary shares.
- Offering Price: $14.00 per share.
- Over-Allotment Option: Up to an additional 570,000 shares exercisable for 30 days.
- Proceeds to Company: $0. The Company is not selling any shares and will not receive proceeds from this transaction.
Material Changes
The primary material event is the execution of an Underwriting Agreement with Morgan Stanley & Co. LLC and Morgan Stanley & Co. International plc. Selling shareholders agreed to sell the shares for resale to the public. The closing of the offering is expected on March 20, 2013, subject to customary conditions.
Outlook, Risks, and Contingencies
The Underwriting Agreement includes customary representations, warranties, and indemnification provisions. Fabrinet has agreed to indemnify the Underwriters against various liabilities, including those under the Securities Act of 1933. A press release announcing the pricing was issued on March 15, 2013. No specific forward-looking guidance or operational risks were detailed in this specific filing beyond the standard terms of the underwriting agreement.
Investor Verification Checklist
- Verify the identity of the Selling Shareholders to understand potential dilution or changes in ownership structure.
- Confirm the final closing date of the offering, currently expected to be March 20, 2013.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification obligations and termination provisions.
- Check the press release (Exhibit 99.1) for any additional commentary on the market conditions or strategic rationale for the sale.